Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for Carfilzomib

1 Open Trial

Trial Type Protocol No. &
Open Date
Summary

Treatment

VICCHEM1448

09/09/2014

A Multicenter Phase 1/2b Study of the Bruton's Tyrosine Kinase Inhibitor, Ibrutinib (PCI-32765), in Combination with Carfilzomib (Kyprolis TM) in Subjects with Relapsed or Relapsed and Refractory Multiple Myeloma